CG Invites Co., Ltd.

Biopharma advancing precision medicine with drugs, mRNA vaccines, and digital therapeutics.

083790 | KO

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: South Korea
Address:: 서울특별시 강서구 마곡중앙8로 38 마곡동, 강서구
Website:: https://cginvites.com/en
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

CG Invites Co., Ltd. is a biopharmaceutical company specializing in digital genomics and personalized precision medicine. Leveraging its core competency in developing novel chemical and biological drugs—such as Acelex (osteoarthritis), Ivaltinostat (pancreatic cancer), and Camrelizumab (immuno-oncology)—the company has expanded its focus to several key areas. These include whole genome sequencing, contributing to large-scale bio-data projects; the development of personalized, mRNA-based cancer vaccines targeting tumor-specific neoantigens; and digital therapeutics (DTx), exemplified by its HealthOnG platform for diabetes management. The company's strategy is to innovate within the digital genome market by integrating its drug development expertise with cutting-edge genomic and digital health technologies.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for CG Invites Co., Ltd. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Date	Filing	Language	Size	Actions
2025-08-14 00:00	Interim Report 반기보고서 (2025.06)	Korean	1.8 MB
2025-08-14 00:00	Major Shareholding Notification 임원ㆍ주요주주특정증권등소유상황보고서	Korean	34.7 KB

Automate Your Workflow. Get a real-time feed of all CG Invites Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for CG Invites Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
SEYİTLER KİMYA SANAYİ A.Ş. Manufacturer of medical tapes, wound dressings, and first aid plasters for the healthcare industry.	Türkiye	SEYKM
Shaperon Inc. Develops inflammasome inhibitors & nanobodies for inflammatory diseases and cancer.	South Korea	378800
Shedir Pharma Group Develops and sells pharmaceutical, nutraceutical, and dermo-cosmetic products in Italy & Spain.	Italy	SHE
SHIELD THERAPEUTICS PLC Commercializing a novel oral therapy for adults with iron deficiency.	United Kingdom	STX
SHINPOONG PHARMACEUTICAL CO.,LTD R&D-driven pharma firm making APIs, finished drugs, and medical products for global markets.	South Korea	019170
Shionogi & Co.,Ltd. A research-driven pharmaceutical firm creating drugs, diagnostics, and devices for global health.	Japan	4507
Siegfried Holding AG Global CDMO providing development and manufacturing of APIs and finished drugs for the pharma industry.	Switzerland	SFZN
SillaJen, Inc. Develops oncolytic viruses and immunotherapeutics to destroy difficult-to-treat cancer cells.	South Korea	215600
SK biopharmaceuticals Co., Ltd. Develops and commercializes CNS and oncology therapies for global markets, focusing on the U.S.	South Korea	326030
SK Bioscience Co.,Ltd A global biotech firm developing vaccines for diseases like COVID-19, influenza, and shingles.	South Korea	302440